QAU Faculty | Pharmacy | Dr. Amjad Khan

Research Interests Publications Conferences Research Projects

Medication safety; antimicrobial stewardship; pharmacist-led interventions in infectious diseases and nephrology; clinical pharmacy; health systems research and epidemiology; clinical trials; public health

2025

1. Khalid, L., Saleem, K., Mushtaq, S., Hussain, I., Hussain, Z., Hussain, Z., Paracha, R. Z., Khan, A., Chang, J., Fang, Y., & Sajid, I. (2025). Global prediction of antimicrobial resistance trends using statistical and machine learning models: Evaluating national action plan policy impacts through interrupted time series analysis. Journal of Global Antimicrobial Resistance, 46, 214-226. https://doi.org/10.1016/j.jgar.2025.11.022

2. Diversity, equality, and inclusivity in pharmacy services; a scoping review (IJPP-25-0239.R2). International Journal of Pharmacy Practice (Accepted article/in production).

3. Kalsoom, U. E., Khan, A.*, Shah, S. S., Iqbal, A., Mehmood, T., Ahmed, S. M., Khan, N., & Fang, Y. (2026). Implementation of guideline-directed medical treatment for ischemic heart disease management: A knowledge, attitude and practice based cross-sectional survey. PLOS ONE, 21(2), e0338634. https://doi.org/10.1371/journal.pone.0338634

4. Hussain, I., Xu, S., Dong, Y., Rasool, M. F., Ullah, J., Khan, A., Kadirhaz, M., Xu, M., Tang, C., Zhao, W., Khan, FU, Chang, J., & Fang, Y. (2025). Packaging-based visual-storytelling nudge to improve antibiotic adherence in uncomplicated urinary tract infection: a pilot randomized trial in Pakistan. BMC Infectious Diseases, https://doi.org/10.1186/s12879-025-12246-x

5. Khan, A.*, Al-Subari, A. M. A., Mushtaq, S., Hameed, K., Abbas, S., Iqbal, M., Dong, Y., Feng, W., Fang, Y. (2025). Evaluating Rational Drug Use in Developing Countries: A Cross-Sectional Analysis of Prescribing Patterns Against WHO Indicators in Pakistan and Yemen. Pharmacology Research & Perspectives 13(6), e70174. https://doi.org/10.1002/prp2.70174.

6. Kanwal, H., Kalsoom, UE., Khan, A.*, Ryan, T., Quinn, J., & Ryan, C. (2025). Estimation of carbon emissions from inhaled respiratory medicines in Ireland: a cross-sectional study from a national pharmacy claims database from 2020 to 2022. International Journal of Clinical Pharmacy, 1-8. https://doi.org/10.1007/s11096-025-02039-2

7. Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Oncology (in production).

8. Mehmood, N., Khan, A.*, Abbas, S., Mushtaq, S., Fang, Y., Ans, M., & Khan, G. M. (2025). Impact of pharmacist-led educational services in promoting breast cancer awareness. BMC Women’s Health, 25(1), 461. https://doi.org/10.1186/s12905-025-04035-0

9. Kalsoom, UE., Khan, A.*, Mehmood, T., Kanwal, H., Ahmed, N., Mushtaq, S., & Fang, Y. (2025). Self-Reported Health-Related Quality of Life in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions. Value in Health Regional Issues, 50, 101174. https://doi.org/10.1016/j.vhri.2025.101174

10. Akhtar, T. S., Abbas, S., Nisar, G., Samad, A., Khan, J. Z, Khan, A.* (2025). Ineffective Motility Revisited Through High-Resolution Manometry After Chicago Classification v4.0. Journal of Health and Allied Sciences NU. 2025;15:301-7. https://doi.org/10.25259/JHS-2024-10-3-(1603)

11. Said, M. S., Fatima, R., See, O. G., Khan, A., Al-Rawi, M. B. A., Khan, I., & Khan, A. H. (2025). Incidence, Management and Factors Affecting Unsuccessful Treatment Outcomes in Pediatric Multidrug-Resistant Tuberculosis Patients: A Cross-Sectional Retrospective Study in Pakistan. Infectious Microbes & Diseases, 10-1097. https://doi.org/10.1097/IM9.0000000000000182

12. Wahid, A., Ahmad, N., Saleem, F., Khan, A., Khan, A., Khan, F. U., & Khan, F. U. (2025). Time to sputum culture conversion as a predictor of cure in multidrug-resistant tuberculosis patients: a multicenter retrospective cohort study in Pakistan. Monaldi Archives for Chest Disease. April 24. https://doi.org/10.4081/monaldi.2025.3200

13. Dar, M., Khan, A.*, Aleem, A., JABER, A. A., Hussain, M., & KHAN, G. M. (2025). Evaluation of health-related quality of life of female students suffering from primary dysmenorrhea: Findings of a cross-sectional study from Pakistan. Frontiers in Public Health, 13, 1467377. https://doi.org/10.3389/fpubh.2025.1467377

14. Abbas, S., Shah, S. S., Akhtar, T. S., Hameed, K., Mushtaq, S., & Khan, A.* (2025). Urdu adaptation and validation of a disease-specific quality-of-life questionnaire in a Pakistani population of Achalasia. PLOS ONE, 20(4), e0321933. https://doi.org/10.1371/journal.pone.0321933

15. Abbas, S., Akhtar, T. S., Chinnam, S., Mushtaq, S., Ahmad, N., Fang, Y., & Khan, A.* (2025). Optimizing achalasia diagnosis in the era of high-resolution manometry: A Pakistani perspective. JGH Open, 9(3), e70041. https://doi.org/10.1002/jgh3.70041

2024

16. Khan, A.*, Ahmad, S. Q., Akhtar, T. S., Bushra, H. T., Imran, M., Khan, J. Z., Shah, S., Haddayat, N., Mushtaq, S., Dong, Y., Feng, W., & Fang, Y. (2024). Relationship of difficult endoscopic retrograde cholangiopancreatography cannulation and visual characteristics of papilla. JGH Open, 8(12), e70045. https://doi.org/10.1002/jgh3.70045

17. Khan, A.*, Ghulam Hussain, S., Mushtaq, S., Abbas, S., Dong, Y., Feng, W., & Fang, Y. (2024). Prevalence and management of anemia and impact of treatment burden on health-related quality of life in chronic kidney disease and dialysis patients. Journal of Pharmaceutical Policy and Practice, 17(1). https://doi.org/10.1080/20523211.2024.2427779

18. Azim, T., Khan, A. H., Sadiq, F., Sulaiman, S. A. S., Khan, A., & Ain, Q. (2024). Impact of COVID-19 on nephropathy in diabetes mellitus type–II patients: a systematic literature review and meta-analysis. BMC Nephrology, 25(1), 399. https://doi.org/10.1186/s12882-024-03821-6

19. Rzymski, P., Jibril, A. T., Rahmah, L., Abarikwu, S. O., Hashem, F., Lawati, A. A., Martha Morrison, F. M., Marquez, L. P., Mohamed, K., Khan, A., Mushtaq, S., Minakova, K., Poniedziałek, B., Zarębska-Michaluk, D., & Flisiak, R. (2024). Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches. Journal of Medical Virology, 96(9), e29900. https://doi.org/10.1002/jmv.29900

20. Khan, A., Akbar, N., Abbas, S., Mushtaq, S., Ahmad, N., & Khan, A*. (2024). Assessing the quality of life in Hydrocephalic children: A study from Tertiary Care Hospitals in Pakistan. Neuropediatrics. https://doi.org/10.1055/a-2366-8580

21. Mwango, A., Akhtar, T. S., Abbas, S., Abbasi, D. S., & Khan, A*. (2024). Effect of artificial intelligence-aided colonoscopy on the adenoma detection rate: A systematic review. International Journal of Gastrointestinal Intervention, 13(3), 65-73. https://doi.org/10.18528/ijgii240013

22. Yiadom, E. B., Akhtar, T. S., Abbas, S., Abbasi, D. S., & Khan, A*. (2024). Prevalence, causes and management of gastric varices–a literature review. Gastroent Hepatol, 2024; 78(3): 247–258. https://doi.org/10.48095/ccgh2024247.

23. Rafique, S., Ahmad, N., Khan, S., Khan, A., Atif, M., Wahid, A., … Waheed, H. (2024). Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan. Journal of Pharmaceutical Policy and Practice, 17(1). https://doi.org/10.1080/20523211.2024.2332878

2023

24. Mallhi, T. H., Salman, M., Khan, Y. H., Khan, F. U., Butt, M. H., Ung, C. O., Khan, A., & Aftab, R. A. (2023). Editorial: Childhood vaccination and COVID-19. Frontiers in Pediatrics, 11, 1298691. https://doi.org/10.3389/fped.2023.1298691

25. Kanwal, H., Khan, S., Eldesoky, G. E., Mushtaq, S., & Khan, A*. (2023). Management of COPD and Comorbidities in COPD patients by Dispensing Pharmaceutical Care following Global Initiative for chronic Obstructive Lung Disease-Guidelines (GOLD guidelines 2020): A study protocol for a Prospective Randomized Clinical Trial. Heliyon, 9(11), e21539. https://doi.org/10.1016/j.heliyon.2023.e21539

26. Mansoor, S., Butt, AR., Bibi, A., Mushtaq, S., Ullah, I., Alshahrani, F., Mansoor, A., Khan, A*. (2023). Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients. PLOS ONE, 18(9), e0291332. https://doi.org/10.1371/journal.pone.0291332

27. Habiba, UE., Khan, A., Mmbaga, EJ., Green, IR., Asaduzzaman, M. (2023). Use of antibiotics in poultry and poultry farmers- A cross-sectional survey in Pakistan. Frontiers in Public Health, 11, 1154668. https://doi.org/10.3389/fpubh.2023.1154668

28. Hayat, M., Ahmad, N., Khan, S. L. A., Mohkumuddin, S., Siddique, W., Khan, A., & Atif, M. (2023). Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan. BMC Nephrology, 24(1), 118. https://doi.org/10.1186/s12882-023-03167-5

29. Hameed, K., Chinnam, S., Khan, KS., Mushtaq, S.,……..& Khan, A*. (2023). Evaluation of hypertension control among hemodialysis patients in Pakistan: a prospective follow-up study. Blood Pressure Monitoring, 10-1097. http://doi.org/10.1097/MBP.0000000000000656

30. Hayat, M., Ahmad, N.*, Mohkumuddin, S., Khan, S.L.A., Khan, A.H, Haq, N.U., Haque, N., Khan, A. (2023). Frequency, types and predictors of drug therapy problems among non-dialysis chronic kidney disease patients at a tertiary care hospital in Pakistan. PLoS ONE, 18(4), e0284439. https://doi.org/10.1371/journal.pone.0284439

31. Bibi, A., Abbas, S., Mushtaq, S., Mansoor, A., Green, I. R., Mallhi, T. H., ... & Khan, A*. (2023). Knowledge, Attitudes and Perceptions towards COVID-19 Vaccinations: A Cross-Sectional Survey in Pakistan. Medicina, 59(2), 272. https://doi.org/10.3390/medicina59020272

2022

32. Bibi, S., Khan, A.*, Khan, A. H., Khan, M. N., Mushtaq, S., & Rashid, S. A. (2022). Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second-and third-generation drug-eluting stents. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.900798

33. Saleem, S. S., Khan, A.*, Aman, R., Saleem, S. S., Bibi, A., Ahmad, N., ... & Shah, K. U. (2022). Impact of pharmacist-led educational intervention on knowledge of self-management among asthmatic patients: a prospective cohort study. BMJ Open, 12(6), e058861. http://dx.doi.org/10.1136/bmjopen-2021-058861

34. Khan, Y. H., Mallhi, T. H., Alanazi, A. S., Butt, M. H., Khan, A., & Salman, M. (2022). Outbreak of Acute Hepatitis of Unknown etiology in Children; The Critical Role of Healthcare Professionals in Neutralizing Misleading Narratives during the COVID-19 Pandemic. Journal of Medical Virology, 94, 4063-4. https://doi.org/10.1002/jmv.27819

35. Mushtaq, S., Hashmi, A. H., Khan, A., Asad Raza Kazmi, S. M., & Manzoor, S. (2022). Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals. Frontiers in Pharmacology, 1289. https://doi.org/10.3389/fphar.2022.894460

36. Khan, F. U., Khan, A., Khan, F. U., Hayat, K., Chang, J., Khalid, W., ... & Fang, Y. (2022). Assessment of adverse drug events, their risk factors, and management among patients treated for multidrug-resistant TB: A prospective cohort study from Pakistan. Frontiers in Pharmacology, 1270. https://doi.org/10.3389/fphar.2022.876955

37. Khan, A.*, Bibi, S., Kanwal, H., & Hussain, H. (2022). Omicron: a new face of COVID‐19 pandemic. Health Science Reports, 5(2). https://doi.org/10.1002/hsr2.526

38. Khan, F. U., Rehman, A. U., Khan, F. U., Hayat, K., Khan, A., Ahmad, N., ... & Fang, Y. (2022). Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan. International Journal of Environmental Research and Public Health, 19(3), 1574. https://doi.org/10.3390/ijerph19031574

39. Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., ... & Rezaei, N. (2022). COVID‐19 vaccinations: The unknowns, challenges, and hopes. Journal of Medical Virology, 94(4), 1336-1349. https://doi.org/10.1002/jmv.27487

2021

40. Naz, F., Ahmad, N., Wahid, A., Ahmad, I., Khan, A., Abubakar, M., ... & Ghafoor, A. (2021). High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis. BMC Infectious Diseases, 21(1), 1-11. https://doi.org/10.1186/s12879-021-06935-6

41. Khan, F. U., Khan, A., Shah, S., Hayat, K., Usman, A., Khan, F. U., ... & Fang, Y. (2021). Exploring Undergraduate Pharmacy Students Perspectives Towards Antibiotics Use, Antibiotic Resistance, and Antibiotic Stewardship Programs Along With the Pharmacy Teachers’ Perspectives: A Mixed-Methods Study From Pakistan. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.754000

42. Akbar, Z., Rehman, S., Khan, A., Khan, A., Atif, M., & Ahmad, N. (2021). Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study. Journal of Pharmaceutical Policy and Practice, 14(1), 1-9. https://link.springer.com/article/10.1186/s40545-021-00348-1

43. Hussain, H., Ali, I., Wang, D., Hakkim, F. L., Westermann, B., Ahmed, I., Ashour, M.A., Khan, A., ... & Shah, S. T. A. (2021). Glycyrrhetinic acid: A promising scaffold for the discovery of anticancer agents. Expert Opinion on Drug Discovery, 16(12), 1497-1516. https://doi.org/10.1080/17460441.2021.1956901

44. Bibi, S., Khan, A.*, Nadeem, A., Mushtaq, S., & Khan, G. M. (2021). Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents. PLOS ONE, 16(6), e0253290. https://doi.org/10.1371/journal.pone.0253290

45. Abubakar, M., Ahmad, N., Ghafoor, A., Latif, A., Ahmad, I., Atif, M., Saleem F., Khan, S., Khan, A., ... & Khan, A. H. (2021). Treatment outcomes of extensively drug-resistant tuberculosis in Pakistan: a countrywide retrospective record review. Frontiers in Pharmacology, 12, 640555. https://doi.org/10.3389/fphar.2021.640555

46. Ahmed, A., Saqlain, M., Bashir, N., Dujaili, J., Hashmi, F., Mazhar, F., Khan, A., ... & Awaisu, A. (2021). Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan. Quality of Life Research, 30(6), 1653-1664. https://doi.org/10.1007/s11136-021-02771-y

47. Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., ... & Fang, Y. (2021). Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International Journal of Environmental Research and Public Health, 18(3) 1320. https://doi.org/10.3390/ijerph18031320

2020

48. Khan, A.*, Bibi, A., Sheraz Khan, K., Raza Butt, A., Alvi, H. A., Zahra Naqvi, A., ... & Ahmad, N. (2020). Routine pediatric vaccination in Pakistan during COVID-19: how can healthcare professionals help? Frontiers in Pediatrics, 8, 859. https://doi.org/10.3389/fped.2020.613433

49. Chatha, Z. F., Rashid, U., Olsen, S., Din, F. U.*, Khan, A.*, Nawaz, K., Gan, S. H., & Khan, G. M.* (2020). Pharmacist-led counselling intervention to improve antiretroviral drug adherence in Pakistan: a randomized controlled trial. BMC Infectious Diseases, 20(1), 1-10. https://doi.org/10.1186/s12879-020-05571-w

50. Mushtaq, S., Akhter, T. S., Khan, A.*, Sohail, A., Khan, A.*, & Manzoor, S. (2020). Efficacy and safety of generic sofosbuvir plus daclatasvir and sofosbuvir/velpatasvir in HCV genotype 3-infected patients: real-world outcomes from Pakistan. Frontiers in Pharmacology, 11, 550205. https://doi.org/10.3389/fphar.2020.550205

51. Mallhi, T. H., Khan, Y. H., Alotaibi, N. H., Alzarea, A. I., Tanveer, N., & Khan, A. (2020). Celebrating Eid-ul-Adha in the era of the COVID-19 pandemic in Pakistan: potential threats and precautionary measures. Clinical Microbiology and Infection, 26(12), 1714-1715. https://doi.org/10.1016/j.cmi.2020.07.019

52. Ahmad, N., Wahid, A., Khan, A., Atif, M., & Khan, A. (2020). Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan. Drugs & Therapy Perspectives, 36(9), 396-403. https://doi.org/10.1007/s40267-020-00763-5

53. Mushtaq, S., Mansoor, A., Umar, M., Khan, A., Siddiqi, S., & Manzoor, S. (2020). Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan. Journal of Medical Virology, 92(12), 3475-3487. https://doi.org/10.1002/jmv.25745

2019

54. Mallhi, T. H., Khan, Y. H., Khan, A., Alotaibi, N. H., Alzarea, A. I., & Hashmi, F. K. (2019). The association of HIV and easy access to narcotics in Pakistan; calling drug policy makers. Journal of Pharmaceutical Policy and Practice, 12(1), 1-4. https://doi.org/10.1186/s40545-019-0199-5

55. Rehman, N. U., Hussain, H., Ali, L., Khan, A., Mabood, F., Shinwari, Z. K., ... & Al-Harrasi, A. (2019). Chemical constituents of acridocarpus orientalis and their chemotaxonomic significance. Chemistry of Natural Compounds, 55(3), 586-588. https://doi.org/10.1007/s10600-019-02752-1

56. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., & Mushtaq, S. (2019). Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study. BMC Public Health, 19(1), 1-13. https://doi.org/10.1186/s12889-019-6796-z

57. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Mushtaq, S., Ahmad, N., & Khan, I. (2019). Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study. Journal of Pharmaceutical Policy and Practice, 12(1), 1-13. https://doi.org/10.1186/s40545-019-0169-y

58. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Ahmad, N., & Gan, S. H. (2019). Evaluation of factors affecting time to achieve dry weight among hemodialysis patients using bioimpedance spectroscopy. Irish Journal of Medical Science (1971-), 188(1), 311-319. https://doi.org/10.1007/s11845-018-1813-2

2018

59. Ahmad, N., Khan, A. H., Khan, I., Khan, A., & Atif, M. (2018). Doctors’ knowledge of hypertension guidelines recommendations reflected in their practice. International Journal of Hypertension, 2018. https://doi.org/10.1155/2018/8524063

60. Khan, I., Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Hamzah, A. B. A., Ahmed, N., & Khan, A. (2018). Effect of socio-demographic factors on endogenous biomarkers (cystatin C and creatinine) among elderly chronic kidney disease patients: a cross-sectional study. International Urology and Nephrology, 50(6), 1113-1121. https://doi.org/10.1007/s11255-018-1834-9

61. Bitar, A. N., Khan, A. H., Khan, A. (2018). Clinical assessment, evaluation, and categorization of medication errors. International Journal of Biology, Pharmacy and Allied Sciences, 7(12), 2104-2119. https://doi.org/10.31032/IJBPAS/2018/7.12.4601

62. Wahab, A., Khan, G. M., Sharifi, M., Khan, A., Khan, A., & Khan, N. (2018). Preparation, solid state characterization and evaluation of ketoprofen-glucosamine HCl solid dispersions. Archives of Pharmacy and Pharmaceutical Sciences, 2: 010-019. https://www.heighpubs.org/hps/apps-aid1007.php

2017

63. Rehman, F. U., Shah, K. U., Shah, S. U., Khan, I. U., Khan, G. M., & Khan, A. (2017). From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opinion on Drug Delivery, 14(11),1325-1340. https://doi.org/10.1080/17425247.2016.1218462

64. Khan, A.*, Khan, A., Wazir, N. N., Ullah, N., & Khan, O. H. (2017). Relapse multifocal osteomyelitis secondary to septicemia: A case study. Archives of Pharmacy Practice, 8(1), 31-34. https://archivepp.com/article/relapse-multifocal-osteomyelitis-secondary-to-septicemia-a-case-study

65. Daar, J., Khan, A., Khan, J., Khan, A., & Khan, G. M. (2017). Studies on self-nanoemulsifying drug delivery system of flurbiprofen employing long, medium and short chain triglycerides. Pak. J. Pharm. Sci, 30(2), 601-606.

66. Khan, A., Khan, J., Irfan, M., Naqvi, S. B. S., Khan, G. M., Shoaib, M. H., ... & Khan, A. (2017). Validation and application of high performance liquid chromatographic method for the estimation of metoclopramide hydrochloride in plasma. Pak J Pham Sci, 30(1), 143-147.

67. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A., & Khan, I. (2017). Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor. Value in Health, 20(9), A864. https://doi.org/10.1016/j.jval.2017.08.2509

68. Iftikhar, T., Rauf, M. K., Sarwar, S., Badshah, A., Waseem, D., Tahir, M. N., Khan, A., ... & Khan, G. M. (2017). Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes. Journal of Organometallic Chemistry, 851, 89-96. https://doi.org/10.1016/j.jorganchem.2017.09.002

69. Dar, M. J., Ali, H., Khan, A., & Khan, G. M. (2017). Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa. Journal of drug targeting, 25(7), 582-596. https://doi.org/10.1080/1061186X.2017.1298601

2016

70. Siddiqui, M. A., Khan, A., & Zaka, M. (2016). A review of structure activity relationship of amiodarone and its derivatives. Open Journal of Medicinal Chemistry, 6(02), 37. 10.4236/ojmc.2016.62003

71. Khan, A.*, Khan, A. H., Adnan, A. S., Syed Sulaiman, S. A., Gan, S. H., & Khan, I. (2016). Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyper-and/or hypotension: a systematic review. BioMed Research International, 2016. https://doi.org/10.1155/2016/9710965

72. Khan, A., Raja, M. H., Khan, A., Khan, M. W., & Khan, G. M. (2016). Synthesis and Assessment of a New Tetrahydrogeraniol Derivative as Penetration Enhancer for Transdermal Drug Delivery. Journal of Glycomics and Metabolism, 1(1), 45-53.

2015

73. Hussain, H., Jabeen, F., Al-Harrasi, A., Ahmad, M., Mabood, F., Hussain, J., Hassan, Z., Rehman, N., Green, I. R., Khan, A., ... & Krohn, K. (2015). Seimisochromenes A and B: two new dihydroisochromenes from the endophytic fungus, Seimatosporium sp. Journal of Asian natural products research, 17(4), 348-351. https://doi.org/10.1080/10286020.2014.972383

74. Hussain, H., Krohn, K., Al-Harrasi, A., Kouam, S. F., Abbas, G., Raees, M. A., Badshah, A., Shah, A., Zahoor, A., Khan, A.,... & Schulz, B. (2015). Microdiplanol and microdiplane: a new m-anisaldehyde and a new 24-methylcholestanol derivative from the endophytic fungus Microdiplodia sp. Journal of Asian natural products research, 17(7), 733-737. https://doi.org/10.1080/10286020.2014.989221

75. Khan A., CH, M. I., Khan, J., Khan, G. M., Hanif, M., & Khan, A. (2015). Formulation development and in vitro characterization of sustained release matrix tablets of verapamil HCl using synthetic and natural polymers. Lat. Am. J. Pharm, 34(2), 277-82.

76. Hussain, A., Khan, G. M., Khan, N. R., Khan, A., Rehman, S., Asif, H. M., ... & Yusuf, A. L. I. (2015). Transdermal Diclofenac Potassium Gels: Natural Penetration Enhancers, Can Be Effective? Lat. Am. J. Pharm, 34(5), 1022-9.

2014

77. Hussain, H., Root, N., Jabeen, F., Al-Harrasi, A., Al-Rawahi, A., Ahmad, M., Hassan, Z., Abbas, G., Mabood, F., Shah, A., Badshah, A., Khan, A., ... & Krohn, K. (2014). Seimatoric acid and colletonoic acid: Two new compounds from the endophytic fungi, Seimatosporium sp. and Colletotrichum sp. Chinese Chemical Letters, 25(12), 1577-1579. https://doi.org/10.1016/j.cclet.2014.06.006

2013

78. Wahab, A., Khan, A., & Khan, G. M. (2013). Preparation and evaluation of solid dispersions of ibuprofen using glucosamine HCl as a carrier. British Journal of Pharmaceutical Research, 3(4), 722-733. http://www.sciencedomain.org/review-history.php?iid=234&id=14&aid=1551

PATENTS

1. Khan A, Mushtaq S, Alshahrani F, Rashah KA, Mopuri R, Chinnam S, Bobbala P, Yallur BC.

Title of the invention: Smart device for the analysis of metabolic disorders

Patent number: 6303315

Status: Granted on 21 August 2023

Patent office: United Kingdom

2. Chinnam S, Farid A, Ullah A, Badar M, Mohaini MHA, Lakkaboyana SK, Mushtaq S, Alsalman AJ, Khan A, Hawaj MAI, Almuhaini RA.

Title of the invention: Artificial Intelligence device for prediction of diabetes

Patent number: 6301395

Status: Granted on 14 August 2023

Patent office: United Kingdom

PAPERS PRESENTED IN INTERNATIONAL CONFERENCES

1. Khan, A., & Fang, Y. (2025). HSD101 Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions. Value in Health, 28(12), S394. Poster presentation at the ISPOR Europe, November 9-12, 2025, Glasgow, UK.

10.1016/j.jval.2025.09.1762

2. Mushtaq, S., Lim, A. G., Khan, A., & Fang, Y. (2025). CO212 Resistance-Driven Treatment Failure: A Challenge to HCV Elimination in Pakistan. Value in Health, 28(12), S85. Poster presentation at the ISPOR Europe, November 9-12, 2025, Glasgow, UK. 10.1016/j.jval.2025.09.313

3. Khan, A., Yu Fang. Assessing the Role of Parents and Clinicians in Evaluating the Co-occurrence of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder in the Pediatric Population of Pakistan. Poster presentation at the 23^rd Asian Conference on Clinical Pharmacy (ACCP 2024), July 25-28, 2024, Hong Kong.

4. Khan, A. (Invited Speaker). High-Resolution Manometry (a Gold Standard) for Diagnosis and Classification of Achalasia. Oral presentation at the 1st International Conference on innovations in chemistry, Biochemistry, Biotechnology & Bioinformatics (ICBBB-2022), December 15-17, 2022, The Islamia University of Bahawalpur (IUB), Pakistan.

5. Khan, A. (Invited Speaker). Knowledge, attitude and perception of Pakistani population towards COVID-19 vaccination and role of Pharmacist in dispelling vaccine myths. Oral presentation at the the 2nd International Seminar & Call For Paper (ISCP) UTA 45 Jakarta on “Promotive, Preventive, and Early Detection of Covid 19”, December 18-19, 2021, UTA 45 Jakarta, Indonesia.

6. Khan, A. (Invited Speaker). Healthcare products Use: Pharmacovigilance & Pharmacoeconomics-Evidence based selection. Oral presentation at the 11th Public Annual Public Health Conference, Sep 23-34, 2021, Health Services Academy (HSA), Islamabad, Pakistan.

7. Khan, A. (Invited Speaker). Routine pediatric vaccination in Pakistan during COVID-19: How can healthcare professionals help? Oral presentation at the 1^st International Seminar & Call For Paper (ISCP) on “Herbal Medicine for Covid-19 and How To Overcome With Pandemic Situation”, December 05-6, 2020, UTA 45 Jakarta, Indonesia.

8. Khan, A., (Invited Speaker) & Mushtaq, S. Assessment of depression among hemodialysis patients in different dialysis facilities. Oral presentation at International Scientific Drug Conference of Asia on “Research, Development and Innovations for Global Healthcare”, October 17, 2020, ST. Dominic College of Asia, Philippines.

9. Khan, A., (Invited Speaker) Khan, A.H., & Mushtaq, S. A comparative study on depression among hemodialysis patients in different dialysis facilities. Oral presentation at 20^th International Pharmacy Conference & Exhibition (IPCE) on Recent Advancements, Future Trends & Challenges in Pharmacy, 27-30^th October 2019, PC Hotel, Lahore, Pakistan.

10. Khan, A., Khan, A. H., Sulaiman, S. A., Adnan, A. S., & Mushtaq, S. Prevalence and evaluation of factors associated with depression among hemodialysis patients. [Oral presentation (Abstract code: OPP24) at 1^st JoPPP Conference on Pharmaceutical Policy and Practice Research, 28-29^th August 2019, Concorde Hotel, Shah Alam, Selangor, Malaysia.

11. Khan, A., (Invited Speaker) Khan, A.H., & Mushtaq, S. Evaluation of factors associated with late Dry-weight achievement among hemodialysis patients: Bioimpedance spectroscopy interpretation. 3rd International Conference on Recent Advancement in Pharmaceutical Research and Drug Delivery QAU Islamabad, Pakistan. Feb 19-20, 2019.

Khan, A., Khan, A. H., Sulaiman, S. A., Adnan, A. S., & Khan, I. Effect of calcium channel blockers on blood pressure in hypertensive hemodialysis patients. [Oral Presentation (Abstract code: ABS-214) at 17th Asian Conference on Clinical Pharmacy (ACCP 17), 28-30th July 2017, Yogyakarta, Indonesia].

13. Khan, A. (Invited Speaker). Healthcare products Use: Pharmacovigilance & Pharmacoeconomics-Evidence based selection. Oral presentation at the 11^th Public Annual Public Health Conference on “Contemporary Medicines, Health Technologies and Vaccines for Emerging Public Health Risks”, September 23-24^th, 2021, Health Services Academy, Islamabad, Pakistan.

14. Khan, A., Khan, A. H., Adnan, A. S., Sulaiman, S. A., & Khan, I. (2017). Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor. Value in Health, 20(9), A864. (Abstract code: PMD4). Poster presented at ISPOR 6th Latin America Conference, September 15-17^th, 2017, Brazil. DOI: https://doi.org/10.1016/j.jval.2017.08.2509 (IF: 5.725).

15. Khan, I., Khan, A. H., Adnan, A. S., Aftab, R. A., & Khan, A. Effect of BMI on Serum Cystatin C among Elderly CKD type 2 Diabetic Patients (Abstract code: PP1630). Poster presented at International Conference on Pharmacy Education & Practice (ICPEP), 29-31 January 2016, Batu Feringghi Penang, Malaysia.

Khan, I., Khan, A. H., Adnan, A. S., Aftab, R. A., & Khan, A. Usefulness of Serum Cystatin C in Malaysian Elderly CKD Patients with type2 Diabetes Mellitus and Nephropathy. [Oral Presentation (Abstract code: PO1625) at International Conference on Pharmacy Education & Practice (ICPEP), 29-31 January 2016, Batu Feringghi Penang, Malaysia].

17. Khan, I., Adnan, A. S., Khan, A. H., & Khan, A. Role of Cystatin C in renal impairment among elderly CKD patients with type 2 Diabetes Mellitus (Abstract code: PP07). Poster Presented at 32nd Annual Congress of Malaysian Society of Nephrology, 29th April-1st May 2016, Persada Johor International Convention Centre, Johor Bahru, Malaysia.

Khan, A., Adnan, A. S., Khan, A. H., & Khan, I. Determination of optimal timing for blood pressure measurement in the management of Hypertensive Hemodialysis patients by using Body Composition Monitoring (BCM). (Abstract code: PP43). Poster Presented at 32nd Annual Congress of Malaysian Society of Nephrology, 29th April-1st May 2016, Persada Johor International Convention Centre, Johor Bahru, Malaysia.

International Conferences, Seminars, and Workshops Organized

1. Organizer of: Scientific session on “Publishing high quality research: What you need to know” sponsored by QAU Pakistan & University of Huddersfield, UK on July 26, 2022.

2. Organizer of: 4th International Conference (virtual) on “Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious diseases” sponsored by WHO Pakistan and ORIC QAU, Islamabad Pakistan on October 10, 2020.

3. Organizer of: 02-Days 3rd International Conference on "Recent Advancement in Pharmaceutical Research and Drug Delivery" sponsored by HEC, Pakistan on Feb 19-20, 2019.

Conferences, Seminars, and Workshops Attended:

I have actively participated in a wide range of national and international conferences, seminars, and workshops. Notable among these are the FIP Online Course on Digital Health in Pharmacy (International Pharmaceutical Federation, May 2023), and the International Seminar on “Improving Stroke Care in Low and Middle Income Countries” (COMSTECH-ICCBS, Jan 2022). I presented at the 2nd International Seminar & Call for Papers (ISCP) and the 1st ISCP organized by UTA 45 Jakarta, Indonesia (2021, 2020). I attended the 11th Annual Public Health Conference at the Health Services Academy, Islamabad (2021), supported by UK Aid and UNICEF. I also participated in the International Scientific Drug Conference of Asia (ST. Dominic College of Asia, Philippines, Oct 2020), the 4th International Conference on Integrative Multidisciplinary Nanomedicine at Quaid-i-Azam University (Oct 2020), and the 20th International Pharmacy Conference & Exhibition (Pakistan Pharmacists Association, Lahore, Oct 2019). Additional engagements include the 1st JoPPP Conference on Pharmaceutical Policy and Practice Research in Malaysia (Aug 2019), 3rd International Conference on Pharmaceutical Research and Drug Delivery (QAU, 2019), and several capacity-building seminars and workshops such as the National Seminar on Intellectual Property System of Pakistan (QAU, 2018), Cochrane Systematic Review Workshop at Universiti Sains Malaysia (2015), and the 2nd International Workshop on Pharmacy Practice (QAU, 2014). Earlier contributions include workshops on pharmaceutical policy (University of Auckland, 2013), biodiversity and climate change (SBB University, 2013), TB care in private pharmacies (Dev-Net, 2013), and quality assurance in higher education (Gomal University, 2010). I have also attended the 17th and 16th International Pharmacy Conferences organized by the Pakistan Pharmacists Association (2012, 2011), underscoring my sustained engagement in professional development and academic exchange.

1. RESEARCH PROJECTS PRESENTLY UNDER INVESTIGATION

S/No

Project Title

Principal / Co-Principal Investigator

Amount (Rs.)

Sponsoring Agency

Duration

Evaluation and Management of COPD and other Comorbidities in COPD Patients by Dispensing Pharmaceutical Care

following the GOLD guidelines 2020: A Prospective Clinical Trial

Principal Investigator

1.373

Millions

Higher Education Commission, Pakistan.

2 years

(Status: Completed)